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Usinil the ketone compound mctyrapone (MPOH) a~t ~ ~ubxtrate for carbon>.l r~duetion it ha~ I~en verified for the firit tinny that vartou= i'~¢nnanenl 
cell Iinq::~ iB culture ~:xpre~ ;~rbonyl redu¢inll ~etivity, ThiJt i~t even true for the dcdifferenlinted and t~brohla~toid cell line V79. emplm~ixin~ the 
essentiality oF this metabolic palhwa?. MPON redu~in~ ennyme at:tivitic~ arc located in the endoplasmi¢ reticulnm as wc|l a~ in the cytoplasm 
of Ih~ ¢elb;. Compared to MPON-redue.lase in rat liver mi~ro~ome~, noirnmunoloi~ical ht~mt~lol, ly to miero~omal C~.REV7 rat liver h~patoma cell 
MPON.reductas¢ could be detected, indientin~ dilTcrenc~s in antigenic determimtnts between the enzymes of tl~t~ olid orilan and r~;tpective c ll.~{ 
in continuous culture. 
Melynipon¢ cMPON)" C~rbonyl rttdut:ta~¢: R,~:duetive metabolism; C¢11 culture 
1, INTI~ODUCTION 
Metabolic reduction is the counterpart to oxidative 
pathways in the detoxication of" many xenobiotics, This 
is especially true for lipophilic compound.~ bearing nitro 
or carbonyl groups [1], Carbonylic substances often ex- 
ert toxic effects on living matter, e,g. inhibition of 
growth or interferences witl~ metabolic reactions of the 
cell [2] and, therefore, have to be metabolized im- 
mediately, Aromatic and aliphatic aldehydes and 
kctones frecluently undergo carbonyl reduction as a 
first metabolic step prior to their further metabolism 
and elimination [3]. The enzymes mediating carbonyl 
reduction belong to the aldo-keto reductase family and 
comprise carbonyl reductase (EC 1.1.1.184), aldehyde 
reductase (EC 1.1,1,2) and aldose reductase (EC 
1.1,1.21). Furthermore, enzymes like NAD(P)H:ClUi- 
none-oxidoreductase (NQR, EC 1.6,99.2), dihydrodiol 
dehydrogenase (DDH, EC 1,3.1.20), and hydro×y- 
steroid dehydrogenases might be involved in carbonyl 
metabolism. In addition to their contribution to the 
deto×ication process carbonyl reductases seem to play 
significant roles in the biotransfornmtion of physio- 
logically occurring substances, uch as steroids [41, pro- 
staglandins [5] and biogenic amines [6]. Carbonyl 
reducing enzymes have been characterized in man and 
animal [7], but little is known about their expression in 
cells in continuous culture. 
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In previous investigations we purified and charac, 
terized a carbonyl reductase from mouse liver micro- 
somes using the ketone metyrapone (MPON) as sub- 
strate [8]. Moreover, we developed a method of HPLC 
analysis for direct determination of the reduced alcohol 
product metyrapol (MPOL)and, besides this, we raised 
antibodies against he microsomal mouse liver MPON- 
reductase to investigate immunological homologies to 
respective nzymes of other tissues and species. 
Up to now MPON reducing enzymes have been 
found in mouse [8], rat [9], rabbit [10] and guinea pig 
[11] tissues. However, about their existence in perma- 
nent cell lines nothing is known, The present study has, 
therefore, been undertaken i  order to establish wheth- 
er continuous cell lines of human and rodent origin 
besides their expression of cytochrome P-450 isozymes 
[121, also express enzymes mediating carbonyl reduc- 
tion, information of possible value also to other groups 
working on the enzymology of reductases. 
2. MATERIALS AND METHODS 
2.1. Chemicals 
Metyrapone was purclmsed from Fluka AG (Buchs, CH), En- 
zy matic tests were performed using NADP*, G-6-P, G-6-P-DH from 
Boehringer Nlannheim (Mannheim, FRG), For HPLC acetonitrile of 
HPLC-grade from E. Merck (Darmstadt, FRG) was used, Ham's F 12 
and NCTC'Cell Culture media were from Flow (Meckenl~eim. FRG), 
Dulbecco M EM-medium, penicillin, streptomycin and 4'6-diamidin- 
2-phenylindol-dihydrochlorid (DAPI) as well as diphenyl-hydamoin 
(DPHI frona Boel~ringer Mannheirn (FRG), All other chemicals were 
of highest commercially available grade, 
2,2, Cell ct..Iture 
2.2, 1. Characteristics of cell lines used in this work 
Dedifferentiated and fibroblastoid V79 cells were originally 
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he, laced from Chlne~' hamtl~r lunl~ I I l l ,  The cell line NC'I,H;I;~2 w~ 
derived front ~ human hlnll tumor h~vin~ morpholollK~Id and fun~. 
tlonal rextur¢os of Clara celh [l~tl. H411EC3/O ~ and C2REV? are 
detcendanl~, of ll~e Reul~r Fl~l hep~mma ,;ell line il4,1~l. 
1*I411Ec~'3~G ~ had been in|¢rmil|~nlly ~ultured in ~lu¢ow.fre¢ 
medium 118] to ~ele~| Iho~e cells betnll able to perform 
tilu¢on~ollenesl~ t a marker for liver, specific, fun¢lloft~, C2REV? 
o~'ll~lnated in a ~el¢¢ted ¢lon,~, re.¢~pressin~l Ilver.~peell'l¢ fuFdlon~, 
The la~ter 3 ~ell I ln~ ~r¢ differentiated, I,e, ih,~y po~e~ spwifi~ at. 
tributes of Iheir Ilssue of oriilln I I?, 181, 
IO ~ ceils of V?9 attd 4 x l0 ~ ¢¢tls of the other 3 line~ were ~eeded 
in I00 mm Or¢lner pills|It di~he,~ or2~ cm ~ t:dfculture tqa~k~. V',~9.nd 
NCI.H322 were llrawn In D~IEM medium completed with 10% Iv/v) 
foetal ~alf serum; 100 u/ml penicillin trod 10O/~ll/ml .~treplomy¢in at 
]? 'C in an ~tmo~pltere of 5% CO=/9~% O=. H411ECMG ~ and 
C2REV? were cull tired in I~lam'~ F I2tNCTC 13 $ medium (I :1 ) with 
5% (v/v) foetal ¢~lr serum t~uppletnent of antlbiotl¢~ and ~ulturlnl~ 
was the same as before), Medinm wa.~ d~anlled daily bel~innin~ from 
the 3rd day after 5Cellini. For experiment~ cdh were ~rown to their 
optinlum density, n parameter of experience, 
All cell lines nsed in this ~tudy were free of my¢opla~ma a~ jtJdged 
by stainintt with DAPI [191, 
2.L Prep#ration of s~hcelhdm'fraclions 
The monolayer.~ were rimed twice with isotonic [I .15~;e KCI) Trir. 
HCI buffer, pH 7,4, ser=~ ped off with a rubber policeman in 1 ml bur. 
fer per plate and sedlmcntcd by ¢¢ntrifuBatior~ a( 200 x It. After I0 
s of hornollenization with an Uitraturrax in the cold, the homo=enate 
was centriful~ted 10 mln at 600 x g, 10 mln at 12 000 x g and 60 rain 
at 170 000 x It; all steps bein~ carried out at 4"C, Remainin~snperna. 
tant represents he cytosolic, the sediment the microsomal fraction, 
which wa~ re~uspended in Tris.HCI buffer FH 7.4, 
2,4. hlcttbalions ht culture¢/ moan/at'era 
MPON, dissolved in medium, was added to a final concentration f 
0.06, 0,4 or I mM to dishes having ~.ained the optimum cell density, 
A 501tl aliquot was taken from tile medium after appropriate time in. 
tervals during rite incubation period and the reaction was stopped by 
mixing it witl~ 100/d ice-cold acetonhrile, 'The samples were centri. 
fuged in an Eppendorf centrifuge at 8000 × g for 6 rain in the cold 
to sediment organic material and 20al of the supernatant served for 
HPLC.determination f MPON anti MPOL 
Experiments o investigate a possible induction of carbonyl reduc- 
ing activity by diphenylhydantoin (DPH] were carried out by adding 
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Fill, I, Tl~e redu~:tion of N1PON in V?9 mon~l~ycr~ in culture, Tl~e 
time course of ¢llanllintl con¢¢ntrallon~ of Ih~ reduced ~iccdtol 
mctaboiite N1POL t (~*O)  and Ihe ~ubs|rat,~ NIPON (o~o)  are 
shown, The ¢orrdalion ~;o¢fficten! of Ihe rectan~uhtr l~yparbola~ For 
b,I POL h r ~ ~ 0,990 and of Ihc exponential decay for MPON r ] 
0,987. b, IPON ~va~ cttlded in culture medium |o a final concentration 
Of 60#M, For comparison I1~ |imc co~,lrse of the eon¢~nlratlon of Ihe 
~um of MPON and MPOL i~ ~iven (~===~); n ~ 2. 
2.8. SDS.polrocryhm~ide llel¢lertrophorexL~, itnmunoblottb~ and 
preparation of antibodies 
SDS.polyacrylamide Ilel ¢lcctrophore~l~, immunoblottlnlj and 
prep=lration of antibodi¢~ =qjain~,t the MPON redueta~e from mouse 
Ilvei microsomei were performed Ill tleserib~td previously 121], 
3, RESULTS 
3.t.  Incubations with cells in culture 
During the same time course of all experiments with 
cells in culture the protein content of the cells changed 
only slightly (5-10070) per flask. The formation of  the 
reduced metabolite metyrapol (MPOL) was thus 
mediated by a fairly constant amount of  reducing en- 
zymes. Control experiments without cells showed less 
than 5°70 of  the activity with cells, which was at the limit 
2,5, Incubations with subcellular f actions 
The assay of MPON-reduction was performed by incubating 65/d 
of biological material in a final volume of 75 al at 37°C, After addi- 
tion of 5/,I of a NADPH-regenerating system (final concentrations: 
NADP + , 0,8 raM; G-6-P, 6 raM; G.6-P.DH, 0.35 U; MgCIz, 3 raM) 
the reaction was started by adding 5 al of 15 or 60 mM MPON 
(dissolved in water) to a final concentration f 1 or 4 raM, The reac- 
tion was stopped by transferring 15 ,ul of the incubation mixture into 
45 .~1 ice.cold aeetonitrile, proceeding further as described above. 
Respective controls were performed without biological material, 
2.6. Determination of metyrapone (MPON) and metyrapol (MPOL) 
by HPLC 
MPON and its reduced alcohol metabolite MPOL were detected on 
a reversed phase HPLC system, using an Octadeeyl-Si 100 polyol (Ser- 
va, Heidelberg, FRG) matrix column (4.5 mm × 25 cm) and an eluent 
of 30% acetonitrile (v/v) in 30 mM phosphate buffer, pH 7,4. MPOL 
elutes at about 6,5 rain and MPON at 10.0 rain {flow rate: 1 ml/min) 
and are monitored at 254 nm with an UV monitor and HPLC integra- 
tion software (BioRad, Munich, FRG). 
2,7. Determination of protein 
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Fig. 2 Michaelis-Menten kinetic of MPON-reducuon in NCI-H322 
cells in culture. For details o f  incubation conditions ee Section 2, 
Values are means m SD, n = 2-12 (n= 28 altogether), Iteration 
analysis with KINPLT kinetic software .ave a KM of 1.73 ± 0.65 mM 
and a Vmax of 252.5 ± 65.5 pmol/min' mg ~) protein. The correlation 
coefficient for linear regression was r a = 0.93, 
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or detection and which mi~lht be ~u~ed by ¢omponent~ 
of the foetal cal f  serum in the culture m¢dium In ac- 
cordance with [I'7] on ly  ~-4 experiments were carded 
out for  each tirrte interval.. 
Fig, ! ~how~ the decreasin~ concentration of  the 
~ubstrat¢ MPON apd th~ inereaslnll concentration of 
tl~e sub~rateMPOL during a 24 h incubation. The non. 
l inear t ime course of  t l~ecorresponding curves indicates 
ti~at at this ~ubstrateconc=ntration reduction of MPON 
has not reached the maximum velocity. The sum o f  
substrate and product concentrations decrea=es only 
very slightly dur ing the in¢ubation period, sho~in8 that 
oliver pathways of MPON-metabolism, such as N- 
oxidation [221, do not seem to he important, 
In Fig, 2 the kinetics of MPON-reduction in the 
human lung tumor cell line HCI.H322 are 
demonstrated, which gave a calculated V,.,~ of 253 
pmol/mg min"L 
Fig, 3 compares the specific activities of carbonyl 
reduction with varying substrate concentrations of 
MPON in 3 ceil lines, The dedifferentiated, fibroblas. 
told cell line V79 revealed the highest activities. Using 
0.06 and 0.4 mM MPON. in V79 it was twice as high as 
in NCI-H322 and C2REV?. These differences in en- 
zyme activity disappear by increasing the MPON con- 
centration up to 1 raM, Obviously, the maximum 
velocity of MPON.reduction ~an be further enhanced 
in NCI-H322 and C2REV7 with substrate concentra- 
tions higher than t raM, whereas in V79 the maximum 
seems to be reached, However, 4 mM MPON added to 
the cells had a lethal effect on V79 and NCI-H322 after 
24 h of  incubation. 
3.2, MPON-reduction in subcellular fractions 
Concerning the subcellular localization of carbonyl 
reductases, the cell line V79 and NCI-H322 showed 
higher specific activities in both cytosol and micro. 
somes than the cell lines C2REV7 and H4IIEC3/G" (cf, 
'- ~ 125 
'~ 25 
~" 0 ,N .4 
V79 
t .~  ,4 i .OB .4 I 
4 3 12 a 3 i8 4 
NCI-H322 C2REV7 
n 
Fig, 3. The specific activity of  MPOL formation of  cells in culture, 
MPON was added in culture medium to final concentrations of 0,O6, 
0.4 and  1 raM, The incubation t imeswere 24 h (left and right bar) and 
48 h (centre bar), For details see Section 2. Values are means + SD 
(number  of experiments (n) and concentrations of MPON (mM) are 
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V?9 NCI-H322 H4/G= C2REV7 
Fil~, 4, The ~pe¢ifleactlvltyor MPOL formation in pmoi/mln' mj ~ 
prol~ln in cyzo~ol (C) anti miero~0me~ (M] or4 ,cell lineL MPON wa~ 
ttdded to final con~emration or I raM. TIze ineubatiot~s were t:~rrled 
OUl with tt NADPH.resenertttln~ system in dine intervah ransin= 
from I $ to 90 mini For d~tails ee Section 2. Value~ are mean;t ± SD, 
rr ~ 16 of 4 individual preparations, 
Fig. 4). In all 4 lines the cytosolic activities surpassed 
that of the respective microsomes. 
3.3. ]mmunoblot analysis 
Employing the immunoblot technique (Fig. 5) an- 
tibodies against he microsoma[ mouse liver MPON- 
reduclase [23] crossreacted with its homologous antigen 
in rat liver microsomes, but not with any protein of the 
4 cell lines, although equal amounts of protein (7.5/cg) 
were applied. 
3.4. Further investigations 
Inall investigations there was no change in carbony] 
reducing activity in relation to growth cycle or age of 
q 2 3 4 5 
Rat  V79 NCI C2 H4/G-  
Fig. 5. Immunological comparison between MPON reducing en- 
zymes o f  microsomes from rat liver (lane l) and microsomes from 
cells of continuous culture (lane 2 = V79; lane 3 = NCI-H322; lane 
4 = C2REV7; lane 5 = H4I IEC3/G' ) .  For details see Section 2. 
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the ¢ell~ (number o f  passattes). The tndtl~gibtJily of At.kn~wt¢¢#trmem*: TI~|~ ~,;,~k ,~t.~ ~upporled in p~irl by lhe Fortdt 
MPON.rcduct ion  was tested by adding the anti .  dtr Clttmt¢, Fr,=~khtrl {FRCd). We th.~tttk Dr F.J, Wlebvl for 
epileptic diphenylhydantoin (DPH), ~ well.known in- 
ducer or cytochrome P..450 and enhancer of MPON. 
decomposilion [241 to cells in culture. In none of ¢he 4 
cell lines, neither in cytosol nor in microsomes could an 
enhancement of carbonyl reduction be detected, 
4. DISCUSSION 
Tl~e present study demonstrates that permanent cell 
lines express enzymes mediating the reductlve bid- 
transformation of carbonyl compounds. Using the 
ketone compound metyrapone (MPON) as substrate 
the cell lines V79, NCI-H322 and C2REV7 reach similar 
specific activities in culture incubations with MPON- 
concentrations of I raM. 
Concerning the dis:ribution of carbonyl redtlcing en- 
zymes will, in the cell we concentrated on cytosolic and 
microsomal fractions as the main subcelhllar localiza- 
tion of biolransformation enzymes and found in all cell 
lines a cytosolic MPON-reducing activity surpassing 
that of the respective microsomes. Despite the occur- 
fence of a microsomal form of MPON-reducing en- 
zyme in the cultured cells no immunological erossreac- 
tivity was detected with antibodies against the MPON- 
reductase from mouse liver microsomes [23]. This could 
bc due to a change in immunological homology, be- 
tween rat liver as solid organ and C2REV7 rat liver 
hepatoma cells. In contrast, the MPON-reductase in rat 
liver microsomes was demonstrated to have immuno- 
logical homologies with microsomal mouse liver en- 
zyme (Fig, 5) [11]. 
In conclusion, carbonyl reduction seems to be an 
essential metabolic pathway, due to its maintenance in 
all continuous cell lines examined so far. This is even 
true for the dedifferentiated and fibroblastoid V79 
cells, which have poor drug metabolizing enzyme ac- 
tivities [12] and in which high activities of MPON- 
reduction are found. Moreover, MPON-reducing en- 
zymes are expressed independently of growth cycle and 
age (number of passages) of the cultured cells, thus 
again confirming the significance of carbonyl reduction 
as an essential metabolic pathway in normal cell 
physiology. 
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